Paton NI, Cousins C, Sari IP, Burhan E, et al. Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial. Lancet Infect Dis 2025 May 22:S1473-3099(25)00151.
PMID: 40414233